Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Alkermes plc
  6. Company
    ALKS   IE00B56GVS15

ALKERMES PLC

(ALKS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Alkermes plc
Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.

Number of employees : 2 245 people.
Sales per Business
20192020Delta
Product524.5044.8%551.7653.1% +5.2%
Manufacturing and Royalty447.8838.2%484.0046.6% +8.06%
Research and Development52.824.5%1.950.2% -96.32%
License145.7512.4%1.050.1% -99.28%
USD in Million
Sales per region
20192020Delta
United States966.9382.6%839.0080.8% -13.23%
Rest of World200.8217.2%196.5318.9% -2.14%
Ireland3.200.3%3.230.3% +1.19%
USD in Million
Managers
Name Title Age Since
Richard F. Pops Chairman & Chief Executive Officer 57 2011
Iain Michael Brown Senior VP, Chief Financial & Accounting Officer 51 2021
Craig C. Hopkinson, Dr. Chief Medical Officer & EVP-Research & Development 52 -
Thomas Harvey Chief Information Officer & Senior VP-IT - -
Sondra Smyrnios Senior Vice President-Clinical Operations - 2019
Kanchan Relwani, Dr. Senior Vice President-Medical Affairs - 2017
Blair C. Jackson Chief Operating Officer & Executive Vice President 47 2021
David Jose Gaffin Secretary, Chief Legal & Compliance Officer, SVP 48 2018
David Westbrook Anstice Lead Independent Director 71 -
Wendy L. Dixon, Dr. Independent Director 64 2011
Members of the board
Name Title Age Since
Richard F. Pops Chairman & Chief Executive Officer 57 2011
David Westbrook Anstice Lead Independent Director 71 -
Wendy L. Dixon, Dr. Independent Director 64 2011
Nancy J. Wysenski Independent Director 62 2013
Nancy L. Snyderman, Dr. Independent Director 68 2016
Shane M. Cooke Director 57 2018
Richard B. Gaynor, Dr. Independent Director 70 2019
Frank Anders Wilson Independent Director 61 2019
David Antonio Daglio Independent Director - 2020
Brian McKeon Independent Director 57 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 164,089,845 158,746,849 96.7% 3,637,896 2.2% 96.7%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. (Investment Management) 19,312,980 12.0%
Wellington Management Co. LLP 17,552,539 10.9%
The Vanguard Group, Inc. 16,600,489 10.3%
Sarissa Capital Management LP 11,245,000 7.01%
BlackRock Fund Advisors 8,456,105 5.27%
PRIMECAP Management Co. 6,228,300 3.88%
First Trust Advisors LP 3,255,169 2.03%
Geode Capital Management LLC 2,164,439 1.35%
Artisan Partners LP 2,033,387 1.27%
SSgA Funds Management, Inc. 1,947,431 1.21%
Company contact information
Alkermes Plc
Connaught House
1 Burlington Road
Dublin 4

Phone : +353.1.772.8000
Web : http://www.alkermes.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Alkermes plc
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
ALKERMES PLC21.00%3 873
MODERNA, INC.214.44%131 902
LONZA GROUP AG20.01%55 520
IQVIA HOLDINGS INC.35.73%46 608
CELLTRION, INC.-26.60%31 131
SEAGEN INC.-17.54%26 209
PHARMARON BEIJING CO., LTD.54.90%21 498
CUREVAC N.V.-35.40%21 497
ALNYLAM PHARMACEUTICALS, INC.35.87%20 757
HANGZHOU TIGERMED CONSULTING CO., LTD-4.58%20 084
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.57.19%19 737
BIO-TECHNE CORPORATION49.14%18 419
INCYTE CORPORATION-11.12%16 789
PPD, INC.34.28%16 137
NOVAVAX, INC.60.53%13 261
ICON PUBLIC LIMITED COMPANY14.71%11 845
QIAGEN N.V.-2.21%11 796
PRA HEALTH SCIENCES, INC.0.00%10 965
INTELLIA THERAPEUTICS, INC.143.33%9 617
CRISPR THERAPEUTICS AG-23.30%9 409
SYNEOS HEALTH, INC.28.96%9 078